Most people taking topiramate lose between 5% and 10% of their body weight, depending on the dose, how long they take it, and their starting weight. For someone who weighs 200 pounds, that translates to roughly 10 to 20 pounds. A large meta-analysis found that patients on topiramate for more than three months lost an average of about 8 pounds, while longer-term studies show considerably more weight loss over a year or beyond.
What the Clinical Trials Show
The clearest picture comes from controlled trials that tracked weight loss at specific time points. At six months (24 weeks), participants taking topiramate lost between 4.8% and 6.3% of their body weight, compared to 2.6% in people taking a placebo. That means a meaningful chunk of the weight loss is from the drug itself, not just the lifestyle changes that come with being in a study.
The numbers get more impressive with time. In a 60-week trial, treatment groups lost 7.0% to 9.7% of their starting weight, while the placebo group lost just 1.7%. Weight loss continued steadily through the full study period without plateauing, and research suggests that people with obesity may keep losing weight beyond the one-year mark.
For people with a BMI over 30, one study found 4.3% body weight lost at three months and about 24 pounds lost at one year. That’s a meaningful amount, though it’s less dramatic than what newer injectable weight loss medications produce.
Weight Loss Even at Lower Doses
Topiramate causes weight loss across a wide dose range. In a study of migraine patients taking just 100 mg per day (a relatively modest dose), 78% of participants lost weight over three months. The losses ranged from about 2 to 22 pounds, with an average of roughly 7.5 pounds. Only about 22% of patients experienced no weight change at all. This matters because it shows that even people taking topiramate for headaches or seizures, not weight loss, frequently see the scale move.
How Topiramate Causes Weight Loss
Topiramate wasn’t designed as a weight loss drug. It’s FDA-approved only for epilepsy and migraine prevention, and weight loss is officially listed as a side effect rather than a therapeutic benefit. Still, the effect is consistent enough that doctors frequently prescribe it off-label for weight management.
The drug works through several brain pathways simultaneously. It enhances the activity of a calming brain chemical while blocking an excitatory one, which collectively reduces appetite and cravings. It also affects enzymes involved in fat storage and energy use. Most people notice that food simply becomes less interesting: portions shrink naturally, snacking decreases, and the mental “pull” toward eating fades. This appetite suppression tends to kick in within the first few weeks of treatment, though the dose is usually increased gradually over that same period.
The Combination Drug Produces Larger Losses
Topiramate is also available combined with phentermine (an appetite suppressant) in a prescription called Qsymia, which is FDA-approved specifically for weight management. The combination produces notably better results than either drug alone. At 28 weeks, the higher-dose combination led to 9.2% body weight loss, compared to about 5% for topiramate alone at a similar dose. About 66% of people on the combination lost at least 5% of their body weight, versus roughly 39% to 49% for either drug used solo.
The combination works at lower doses of each ingredient than you’d need if taking them separately, which can mean fewer side effects from either one.
Weight Loss Happens Gradually
Don’t expect a dramatic drop in the first week or two. Topiramate is started at a low dose and slowly increased, so the appetite-suppressing effects build over time. Most clinical trials show a steady, continuous decline in weight rather than a sudden drop followed by a plateau. The trajectory looks something like this: noticeable loss by month one or two, meaningful results by three to six months, and continued progress through at least a year for many people.
People with higher starting weights tend to lose more in absolute terms. Someone starting at 250 pounds will typically lose more total weight than someone starting at 180 pounds, even if the percentage is similar.
Weight Typically Returns After Stopping
One important reality: topiramate’s weight loss effect is largely reversible. A prospective study of 241 patients found that among those who lost weight on topiramate, their weight, BMI, and waist circumference all trended back toward their original values within six months of stopping the drug. About 36% of patients in that study had experienced weight loss while on the medication, and the regain pattern was consistent enough that researchers described the weight loss as a “reversible effect.”
The strongest predictor of who would regain weight was a measure of insulin resistance before starting treatment. People with higher insulin resistance were more likely to see their weight bounce back. This suggests that for some people, the underlying metabolic factors driving weight gain remain unchanged by the drug, and they reassert themselves once the medication is removed.
Side Effects That May Limit Use
Topiramate’s weight loss benefits come with real tradeoffs. The most common side effects are tingling or numbness in the hands and feet and cognitive dulling, often described as difficulty finding words, slower thinking, or feeling mentally “foggy.” In clinical trials focused on weight loss, these two categories of side effects were the primary reasons people dropped out. In one small trial for overweight patients with type 2 diabetes, nearly half of the topiramate group didn’t finish the study, largely because of these issues.
The cognitive effects are dose-dependent, meaning higher doses produce more noticeable thinking changes. This creates a practical tension: higher doses produce more weight loss but also more brain fog. Many prescribers try to find the lowest effective dose that produces meaningful appetite suppression without intolerable mental side effects. Other potential issues include taste changes (especially with carbonated drinks), dry mouth, and fatigue, though these are generally milder and tend to improve over time.